Whitney joined as a Senior Consultant in 2017 to lead MEDLIOR’s HTA services. Her combination of industry and public payer experience brings a well-informed perspective to all your HTA projects.
Whitney has worked in HTA and Market Access roles across the UK and Ireland, including as National Health Economics Lead for Daiichi Sankyo UK & Ireland, and as the HTA Team Leader for Pfizer UK’s Oncology portfolio. Prior to working in the pharmaceutical industry, Whitney worked as a Technical Lead in the Technology Appraisals team at the National Institute for Health and Care Excellence (NICE) in the UK. As a Chancellor’s Scholar, Whitney obtained a BHSc (Hons.) from the University of Calgary. She went on to obtain an MSc (Merit) in International Health Policy from the London School of Economics & Political Science, where her dissertation focused on modelling infectious disease in economic evaluation.